You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

36 Results
Regimen
Cancer Type:
Central Nervous System
Intent: Palliative
Aug 2017
Regimen
Cancer Type:
Hematologic, 
Leukemia - Hairy Cell
Intent: Palliative
Mar 2022
Regimen
Cancer Type:
Lung, 
Mesothelioma (Pleural)
Intent: Palliative
May 2019
Regimen
Intent: Palliative
Funding:
New Drug Funding Program
    Trastuzumab (Biosimilar) in combination with Chemotherapy - Metastatic Breast Cancer
New Drug Funding Program
    Trastuzumab (Biosimilar) - Second Line - Metastatic Breast Cancer
May 2024
Drug
Other Name(s): Zelboraf ®
Aug 2023
Drug
Other Name(s): Erivedge®
Oct 2023
Drug
Other Name(s): Venclexta®
May 2024
Drug
Other Name(s): Caprelsa®
Aug 2023
Drug
Other Name(s): Zolinza®
Jun 2019
Drug
Mar 2021
Drug
Other Name(s): Navelbine®
Apr 2023
Drug
Other Name(s): Oncovin® (multiple brands available)
Nov 2017

Pages